Exploration of Health Literacy in Diabetes in Reunion Island and France

NCT ID: NCT06437782

Last Updated: 2025-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-17

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to identify the health literacy profile of diabetic patients in Reunion Island and France in order to obtain information to improve access to information, therapeutic education and to health service. The main question\[s\] it aims to answer \[is/are\]:

Participants will complete the Health Literacy Questionnaire (HLQ) once.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes type1 Diabetes Type 2 Diabetes, Gestational

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

type 1 diabetes closed loop

Questionnaire completion

Intervention Type OTHER

HLQ (Health Literacy questionnaire) will be completed by all included patients once.

type 2 diabetes

Questionnaire completion

Intervention Type OTHER

HLQ (Health Literacy questionnaire) will be completed by all included patients once.

Gestational diabetes

Questionnaire completion

Intervention Type OTHER

HLQ (Health Literacy questionnaire) will be completed by all included patients once.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire completion

HLQ (Health Literacy questionnaire) will be completed by all included patients once.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient with type 1, 2 or gestational diabetes taken care in hospital

Exclusion Criteria

* Patient unable to understand and respect study procedures
* Patient with cognitive disorder
* Patient with serious acute complication due to diabetes within 15 days before inclusion
* Stroke history with neurologic consequences
* Other specific types of diabetes : chronic calcific pancreatitis, iatrogenic, other secondary diabetes, rare monogenic or genetic diabetes due to insulin resistance
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de La Réunion

Saint-Denis, , Reunion

Site Status NOT_YET_RECRUITING

CHU de La Réunion

Saint-Denis, , Reunion

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Reunion

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anna FLAUS

Role: CONTACT

+262262905610

Xavier DEBUSSCHE

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anna FLAUS

Role: primary

Anna FLAUS

Role: primary

+262692995210

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017/CHU/13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.